期刊
PHARMACOLOGY & THERAPEUTICS
卷 122, 期 2, 页码 83-96出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pharmthera.2009.01.005
关键词
Cannabinoid; CB1; CB2; Non-CB1/CB2
资金
- NIH [DA021285]
- NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021285, R01DA014486] Funding Source: NIH RePORTER
Cannabinoids produce a plethora of biological effects, including the modulation of neuronal activity through the activation of CB1 receptors and of immune responses through the activation of CB2 receptors. The selective targeting of either of these two receptor subtypes has clear therapeutic value. Recent evidence indicates that some of the cannabinomimetic effects previously thought to be produced through CB1 and/or CB2 receptors, be they on neuronal activity, on the vasculature tone or immune responses, still persist despite the pharmacological blockade or genetic ablation of CB1 and/or CB2 receptors. This suggests that additional cannabinoid and cannabinoid-like receptors exist. Here we will review this evidence in the context of their therapeutic value and discuss their true belonging to the endocannabinoid signaling system. Published by Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据